AMERICAN SHARED HOSPITAL SERVICES Deferred Tax Assets, Operating Loss Carryforwards
AMERICAN SHARED HOSPITAL SERVICES (AMS) had Deferred Tax Assets, Operating Loss Carryforwards of $1.08 million as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-31
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $1.08M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $651.00K.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $155.00K.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $139.00K.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $1.08M 10-K · filed 2026-03-31 |
| 2024-12-31 | $651.00K 10-K · filed 2026-03-31 |
| 2023-12-31 | $155.00K 10-K · filed 2025-04-04 |
| 2022-12-31 | $139.00K 10-K · filed 2024-04-01 |
| 2021-12-31 | $360.00K 10-K · filed 2023-03-31 |
| 2020-12-31 | $99.00K 10-K · filed 2022-03-30 |
| 2019-12-31 | $117.00K 10-K · filed 2021-04-06 |
| 2018-12-31 | $80.00K 10-K · filed 2020-04-03 |
| 2017-12-31 | $1.42M 10-K · filed 2019-03-29 |
| 2016-12-31 | $2.78M 10-K · filed 2018-03-28 |
| 2015-12-31 | $2.86M 10-K · filed 2017-03-27 |
| 2014-12-31 | $3.42M 10-K · filed 2016-03-30 |
| 2013-12-31 | $3.61M 10-K · filed 2015-04-01 |
| 2012-12-31 | $3.77M 10-K · filed 2014-03-31 |
| 2011-12-31 | $3.33M 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |